Expanding the molecular glycophenotype ontology to include model organisms and acquired diseases

Jean Philippe Gourdine, Nicole Vasilevsky, Lilly Winfree, Matthew Brush, Melissa Haendel

Research output: Contribution to journalConference article

Abstract

Glycans are an underappreciated class of molecules despite the fact that they are implicated in more than 100 known diseases. We have developed an ontology model that captures glycan abnormalities at the molecular level (glycophenotypes) called the molecular glycophenotype ontology (MGPO). Only 30% of known glycosyltransferases have been implicated in human genetic disorders of glycosylation. Ortholog glycosyltransferases from model organism can cover relevant biological information on potential human diseases. Thus, extending MGPO to represent additional phenotypes and support annotation of model organism data will help cross-species comparison. Expansion of MGPO will also include annotation of glycophenotypes from acquired diseases.

Original languageEnglish (US)
JournalCEUR Workshop Proceedings
Volume2285
StatePublished - Jan 1 2018
Event9th International Conference on Biological Ontology, ICBO 2018 - Corvallis, United States
Duration: Aug 7 2018Aug 10 2018

Fingerprint

Ontology
Glycosylation
Molecules

Keywords

  • Diseases
  • Glycans
  • Glycophenotypes
  • Model organisms

ASJC Scopus subject areas

  • Computer Science(all)

Cite this

Expanding the molecular glycophenotype ontology to include model organisms and acquired diseases. / Gourdine, Jean Philippe; Vasilevsky, Nicole; Winfree, Lilly; Brush, Matthew; Haendel, Melissa.

In: CEUR Workshop Proceedings, Vol. 2285, 01.01.2018.

Research output: Contribution to journalConference article

Gourdine, Jean Philippe ; Vasilevsky, Nicole ; Winfree, Lilly ; Brush, Matthew ; Haendel, Melissa. / Expanding the molecular glycophenotype ontology to include model organisms and acquired diseases. In: CEUR Workshop Proceedings. 2018 ; Vol. 2285.
@article{189062bf54654ed9808a58c3ece85a71,
title = "Expanding the molecular glycophenotype ontology to include model organisms and acquired diseases",
abstract = "Glycans are an underappreciated class of molecules despite the fact that they are implicated in more than 100 known diseases. We have developed an ontology model that captures glycan abnormalities at the molecular level (glycophenotypes) called the molecular glycophenotype ontology (MGPO). Only 30{\%} of known glycosyltransferases have been implicated in human genetic disorders of glycosylation. Ortholog glycosyltransferases from model organism can cover relevant biological information on potential human diseases. Thus, extending MGPO to represent additional phenotypes and support annotation of model organism data will help cross-species comparison. Expansion of MGPO will also include annotation of glycophenotypes from acquired diseases.",
keywords = "Diseases, Glycans, Glycophenotypes, Model organisms",
author = "Gourdine, {Jean Philippe} and Nicole Vasilevsky and Lilly Winfree and Matthew Brush and Melissa Haendel",
year = "2018",
month = "1",
day = "1",
language = "English (US)",
volume = "2285",
journal = "CEUR Workshop Proceedings",
issn = "1613-0073",
publisher = "CEUR-WS",

}

TY - JOUR

T1 - Expanding the molecular glycophenotype ontology to include model organisms and acquired diseases

AU - Gourdine, Jean Philippe

AU - Vasilevsky, Nicole

AU - Winfree, Lilly

AU - Brush, Matthew

AU - Haendel, Melissa

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Glycans are an underappreciated class of molecules despite the fact that they are implicated in more than 100 known diseases. We have developed an ontology model that captures glycan abnormalities at the molecular level (glycophenotypes) called the molecular glycophenotype ontology (MGPO). Only 30% of known glycosyltransferases have been implicated in human genetic disorders of glycosylation. Ortholog glycosyltransferases from model organism can cover relevant biological information on potential human diseases. Thus, extending MGPO to represent additional phenotypes and support annotation of model organism data will help cross-species comparison. Expansion of MGPO will also include annotation of glycophenotypes from acquired diseases.

AB - Glycans are an underappreciated class of molecules despite the fact that they are implicated in more than 100 known diseases. We have developed an ontology model that captures glycan abnormalities at the molecular level (glycophenotypes) called the molecular glycophenotype ontology (MGPO). Only 30% of known glycosyltransferases have been implicated in human genetic disorders of glycosylation. Ortholog glycosyltransferases from model organism can cover relevant biological information on potential human diseases. Thus, extending MGPO to represent additional phenotypes and support annotation of model organism data will help cross-species comparison. Expansion of MGPO will also include annotation of glycophenotypes from acquired diseases.

KW - Diseases

KW - Glycans

KW - Glycophenotypes

KW - Model organisms

UR - http://www.scopus.com/inward/record.url?scp=85059865319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059865319&partnerID=8YFLogxK

M3 - Conference article

AN - SCOPUS:85059865319

VL - 2285

JO - CEUR Workshop Proceedings

JF - CEUR Workshop Proceedings

SN - 1613-0073

ER -